Blog

In a significant move for cancer research and patient care, the Association of American Cancer Institutes (AACI) is urging Congress to pass the Clinical Trial Modernization Act (S. 4440). This...

Recent research from Johns Hopkins University has unveiled a compelling link between inherited long telomeres and an increased risk of lymphoid cancers, such as lymphoma. This discovery not only...

Recent findings from researchers at the Johns Hopkins Kimmel Cancer Center highlight a crucial genetic condition linked to unusually long telomeres, which could significantly impact cancer risk and...

In a significant advancement for pancreatic cancer treatment, researchers have reported promising results from a phase 1/2 clinical trial of daraxonrasib, a targeted RAS inhibitor. Conducted by a...

The American Society of Clinical Oncology (ASCO) annual meeting is a significant event in the oncology calendar, serving as a platform for researchers to share their latest findings with the medical...

The recent announcement from The University of Texas MD Anderson Cancer Center about the promising results of daraxonrasib, a new oral RAS inhibitor, brings a glimmer of hope to patients battling...

In a significant development for pancreatic cancer treatment, researchers have unveiled promising results from the RAS inhibitor daraxonrasib, which targets specific mutations that drive this...

Recent developments in cancer research have illuminated a promising path toward earlier diagnosis and more effective treatment for one of the most aggressive forms of breast cancer: inflammatory...

Recent advancements in cancer research have the potential to change the way we approach some of the most aggressive forms of the disease. A groundbreaking study from scientists at The University of...

Recent advancements in medical technology are paving the way for innovative treatment options in the fight against cancer. A systematic review and meta-analysis recently published highlights the...

The recent announcement from The Wistar Institute regarding Dr. Dario C. Altieri’s upcoming transition from his role as president and CEO highlights a pivotal moment not only for the institute but...

The landscape of cancer treatment is constantly evolving, but one critical aspect often overlooked is the support that patients need beyond medical interventions. A recent initiative by researchers...

Recent research from the Icahn School of Medicine at Mount Sinai has made significant strides in understanding why immunotherapy works for some cancer patients but not for others. This discovery...

Recent news from The University of Kansas Cancer Center shines a spotlight on an important advancement in the fight against ovarian cancer. The Honorable Tina Brozman Foundation for Ovarian Cancer...

In a significant advancement for oncology, researchers at the Mayo Clinic have unveiled a groundbreaking artificial intelligence (AI) tool that promises to transform the early detection of pancreatic...

Recent advances in vaccine technology have opened up new possibilities for protecting vulnerable populations from cancer. Scientists at Wits University are making significant strides in vaccine...

In a significant development from South Korea, scientists have successfully advanced a promising new cancer treatment, OCT-598, into clinical trials. This novel drug is designed to target two...

In a groundbreaking study recently published in Nature Medicine, researchers in Italy have unveiled a novel approach to enhancing the efficacy of immunotherapy for patients suffering from advanced...

The landscape of cancer treatment is constantly evolving, and recent advancements in radiopharmaceutical therapy are paving the way for more targeted and effective options for patients. The American...

Recent research highlighted the impact of histotripsy on tumor cellular damage and treatment outcomes in a preclinical model of hepatocellular carcinoma (HCC), a primary liver cancer that often...